中国药物经济学
中國藥物經濟學
중국약물경제학
CHINA JOURNAL OF PHARMACEUTICAL ECONOMICS
2015年
4期
137-138
,共2页
彭菲%刘明铭%宗晓芸%田洁
彭菲%劉明銘%宗曉蕓%田潔
팽비%류명명%종효예%전길
药学干预%多药联合%2型糖尿病
藥學榦預%多藥聯閤%2型糖尿病
약학간예%다약연합%2형당뇨병
Modified Xiaochaihutang%Liver dysfunction%Treatment
目的:探讨药学干预对多药联合治疗2型糖尿病患者疗效的影响。方法收集101例2型糖尿病患者资料,将患者分为药学干预组(A组,57例)和对照组(B组,44例)。比较两组患者治疗效果、用药偏差发生率,记录其用药依从性。结果 A组患者总有效率为96.5%,明显高于B组的79.5%(P<0.05);A组用药偏差发生率明显低于B组(P<0.05);A组用药依从优良率为93.0%,明显高于B组的72.7%(P<0.05)。结论对多药联合治疗的2型糖尿病患者予以药学干预,可有效提高患者服药依从性及治疗效果,并降低药物不良反应发生率。
目的:探討藥學榦預對多藥聯閤治療2型糖尿病患者療效的影響。方法收集101例2型糖尿病患者資料,將患者分為藥學榦預組(A組,57例)和對照組(B組,44例)。比較兩組患者治療效果、用藥偏差髮生率,記錄其用藥依從性。結果 A組患者總有效率為96.5%,明顯高于B組的79.5%(P<0.05);A組用藥偏差髮生率明顯低于B組(P<0.05);A組用藥依從優良率為93.0%,明顯高于B組的72.7%(P<0.05)。結論對多藥聯閤治療的2型糖尿病患者予以藥學榦預,可有效提高患者服藥依從性及治療效果,併降低藥物不良反應髮生率。
목적:탐토약학간예대다약연합치료2형당뇨병환자료효적영향。방법수집101례2형당뇨병환자자료,장환자분위약학간예조(A조,57례)화대조조(B조,44례)。비교량조환자치료효과、용약편차발생솔,기록기용약의종성。결과 A조환자총유효솔위96.5%,명현고우B조적79.5%(P<0.05);A조용약편차발생솔명현저우B조(P<0.05);A조용약의종우량솔위93.0%,명현고우B조적72.7%(P<0.05)。결론대다약연합치료적2형당뇨병환자여이약학간예,가유효제고환자복약의종성급치료효과,병강저약물불량반응발생솔。
Objective To investigate the influence of pharmacy intervention accept multi drug treatment for patients with type 2 diabetes melitus.Methods We selected 101 cases of patients with type 2 diabetes,patients wil be divided into pharmaceutical intervention group(group A,n=57)and control group(group B,n=44).Comparison of two groups of patients treatment effect,the incidence of medication deviation,recorded their medication compliance. Results A group of patients,the total effective rate was 96.5%,obviously higher than that of B group 79.5%(P<0.05); in group A were significantly lower than B group deviation(P<0.05);A group of compliance for the excelent and good rate was 93.0%,higher than that in B group and 72.7%(P<0.05).Conclusion The pharmacy intervention to be accepted multi-drug combination therapy in patients with type 2 diabetes,which can effectively improve their medication compliance,treatment and reduce the incidence of adverse drug reactions.